
Member of the European Parliament · Croatia EPP
Tomislav Sokol
MEP for Croatia · European People's Party · Hrvatska demokratska zajednica · official EP profile
As of 12 September 2026, Tomislav Sokol (EPP, Croatia) has declared 216 lobby meetings this term - rank 68 of 719 MEPs by declared meetings.
That is one of the fuller declaration sheets in the Parliament - 2.5× the average member, and 22 of 185 within European People's Party.
42% of this MEP's declared counterpart entries, including diplomatic and government entries, carry a declared EU Transparency Register link - below the like-for-like raw Parliament-wide share of 51%.
Compare with the rest: search and sort all 719 MEPs, or see every MEP from Croatia.
Compared with the averages
Transparency this term
Monthly declared meetings (bars) and the share of all counterpart entries carrying a declared Register link, including diplomatic and government entries (line), July 2024 to September 2026. This is the same current-term window as the figures above, beginning 16 July 2024.
Current month, partial through 11 Sep 2026: 0 declared meetings in Sep 2026. Peak: 15 in Nov 2024.
Busiest month: 15 declared in November 2024. Months with no declared meetings have no Register-share value.
Who Tomislav Sokol meets most
| Declared counterpart | Meetings |
|---|---|
| MedTech Europe | 7 |
| European Federation of Pharmaceutical Industries and Associations | 6 |
| AstraZeneca PLC | 5 |
| Novo Nordisk A/S | 5 |
| Merck Sharp & Dohme Europe Belgium SRL | 4 |
Counterparts are merged by resolved Transparency Register identity where possible. An entry counts as register-linked above only when the MEP declaration itself carries a Register link.
Where the meetings cluster
Most-met sectors
Health & pharma (93), Technology & digital (8), Business federations & chambers (7)
Meetings by committee topic
Public Health (72), Internal Market and Consumer Protection (14), D-ME (3), Environment, Climate and Food Safety (3), D-TR (1)
Most recent declared meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 14 Jul 2026 | European Medicines Agency | Member | Health policy |
| 14 Jul 2026 | German Federal Ministry for Economic Affairs and Energy | Shadow rapporteur | Industrial policy |
| 9 Jul 2026 | Hitachi Europe Ltd. ↗ | Shadow rapporteur | Industrial policy |
| 8 Jul 2026 | CEFIC - European Chemical Industry Council; Forum Atomique Européen ↗; GE Vernova | Shadow rapporteur | Industrial policy |
| 8 Jul 2026 | Obnovljivi izvori energije Hrvatska | Member | Renewable energy and industrial policy |
| 7 Jul 2026 | Hyundai Motor Europe ↗; Hydrogen Europe ↗; Acea S.p.A. | Shadow rapporteur | Industrial policy |
| 16 Jun 2026 | DPS - Democratic Party of Socialists of Montenegro | Member | EU Enlargement policy |
| 16 Jun 2026 | LG Energy Solution | Shadow rapporteur | Industrial policy |
| 9 Jun 2026 | EuroNavigator Public Affairs ↗ | Member | EU Policy |
| 9 Jun 2026 | Finnish Ministry of Social Affairs and Health, Special envoy for health and wellbeing | Member | Health Policy |
Show 20 more meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 9 Jun 2026 | The European Steel Association ↗ | Shadow rapporteur | Industrial policy |
| 4 Jun 2026 | Economist and Technology Policy Strategist in Israel | Member | Economic policy |
| 4 Jun 2026 | European Federation of Pharmaceutical Industries and Associations ↗ | Rapporteur | Health Policy |
| 3 Jun 2026 | Volkswagen Aktiengesellschaft ↗ | Shadow rapporteur | Industrial policy |
| 3 Jun 2026 | European Organisation for Research and Treatment of Cancer ↗ | Member | Health Policy |
| 2 Jun 2026 | Screen4Rare; Invest Europe ↗ | Member | Health Policy |
| 2 Jun 2026 | Alpitronic | Shadow rapporteur | Industrial policy |
| 19 May 2026 | UK Minister for Trade, Department for Business and Trade; Executive Vice-President of the European Commission for Prosperity and Industrial Strategy; TotalEnergies SE ↗; Permanent Representation of Spain to the European Union | Shadow rapporteur | Industrial policy |
| 13 May 2026 | A. Menarini Industrie Farmaceutiche Riunite s.r.l. ↗; OM Pharma SA | Rapporteur | Health Policy |
| 13 May 2026 | L'Oréal ↗ | Member | Environmental policy |
| 7 May 2026 | Bavarian Nordic A/S; Bristol-Myers Squibb Company ↗ | Member | Health Policy |
| 6 May 2026 | Permanent Representation of the Republic of Cyprus to the European Union; European Migraine and Headache Alliance ↗ | Rapporteur | Health Policy |
| 6 May 2026 | Sisvel International S.A. ↗ | Member | Internal market policy |
| 5 May 2026 | Nestlé S.A. ↗ | Member | Internal market policy |
| 5 May 2026 | AstraZeneca PLC ↗; Alexion Pharmaceuticals ↗; W.L. Gore & Associates GmbH ↗ | Rapporteur | Health Policy |
| 28 Apr 2026 | European Commissioner for Agriculture and Food | Member | Agricultural policy - geographical indications and traditional terms |
| 28 Apr 2026 | Ireland's Minister for Health; European Confederation of Pharmaceutical Entrepreneurs ↗; American Chamber of Commerce to the European Union ↗ | Rapporteur | Health Policy |
| 22 Apr 2026 | European Water Services a.s.b.l. | Member | Environmental policy |
| 22 Apr 2026 | Reckitt Benckiser ENA B.V.; Triple P (Postive Parenting Program) | Member | Health Policy |
| 16 Apr 2026 | International Fresh Produce Association | Member | Health policy |
The full record is in the official EP declarations.
Roll-call voting record
Recorded votes only. Parliament held 5,568 roll-call votes while Tomislav Sokol held the seat, 537 of them the final vote on a text. A member with no vote recorded may have been on parliamentary business, ill, on leave, or present without voting - the published record does not distinguish these and gives no reason. Votes taken by show of hands or by secret ballot are not recorded by name and are absent here.
How they voted on final texts
Share of the 537 final votes held while seated.
With and against the group
On the 482 final texts where more than half of EPP members casting a vote went one way, and Tomislav Sokol also voted. Groups are not bound to vote together: a Member's mandate is personal and exercised freely, so neither figure is a measure of performance.
Final texts where Tomislav Sokol differed from the EPP majority
| Date | Text | Their vote | EPP majority |
|---|---|---|---|
| 8 July 2026 | B10-0335/2026 – Motion for a resolution (as a whole) | For | Against |
| 8 July 2026 | B10-0336/2026 – Motion for a resolution (as a whole) | For | Against |
| 8 July 2026 | B10-0334/2026 – Motion for a resolution (as a whole) | For | Against |
| 29 April 2026 | B10-0186/2026 – Motion for a resolution | For | Against |
| 29 April 2026 | A10-0042/2026 – Anna Strolenberg – Motion for a resolution (as a whole) | Against | For |
| 29 April 2026 | A10-0091/2026 – Konstantinos Arvanitis – Motion for a resolution (as a whole) | Against | For |
| 29 April 2026 | A10-0051/2026 – Pasquale Tridico – Motion for a resolution (as a whole) | Against | For |
| 28 April 2026 | A10-0047/2026 – Evin Incir, Joanna Scheuring-Wielgus – Motion for a resolution (as a whole) | Abstained | For |
| 11 March 2026 | A10-0021/2026 – Irena Joveva, Mirosława Nykiel – Motion for a resolution (as a whole) | Against | For |
| 11 March 2026 | A10-0016/2026 – Petras Auštrevičius – Motion for a resolution (as a whole) | Abstained | For |
36 further instances are not listed. All roll-call votes.
Unlinked but matchable
87 counterpart entrys in Tomislav Sokol's declarations appear to match an EU Transparency Register entry without being linked in the declaration:
- “EFPIA” - likely European Federation of Pharmaceutical Industries and Associations (3 counterpart entrys)
- “European Patients' Forum (EPF)” - likely European Patients' Forum (EPF) (2 counterpart entrys)
- “MSD” - likely Merck Sharp & Dohme Europe Belgium SRL (2 counterpart entrys)
Matching is automated and can be wrong - see how matching works. Linking the register entry is the fix, and it is the MEP office's to make.